Matches in SemOpenAlex for { <https://semopenalex.org/work/W2783845384> ?p ?o ?g. }
Showing items 1 to 73 of
73
with 100 items per page.
- W2783845384 endingPage "227" @default.
- W2783845384 startingPage "227" @default.
- W2783845384 abstract "INTRODUCTION: Alzheimer's disease (AD) is the most common type of dementia. Plasmapheresis is a procedure consisting of removing the plasma, or specific elements which are considered to be involved in pathological processes. Plasmapheresis could reduce the A beta peptides load in the brain. The objective is to study the safety and efficacy of plasmapheresis for AD. METHODS: Systematic review, with all studies published before April 2016 reviewed. Selected studies included patients with AD treated with plasmapheresis. GRADE was used to assess quality. Efficacy outcomes include: (i) Cognitive, functional and behavior status, through Mini Mental State Examination, and Alzheimer Disease Assessment Scale-Cognitive test; (ii) Plasma and cerebrospinal fluid A beta levels; (iii) Brain-imaging and functional neuroimaging studies. Safety outcomes included side effects related to the treatment. RESULTS: Two papers reporting results from three studies were selected: (i) pilot study (n = 10), (ii) its extended study (12 months more of follow-up) (n = 7), and (iii) clinical trial (n = 39). The quality of evidence was very low. About efficacy, the studies didn't report quantitative results and were inconclusive. The pilot study and its extended study reported (1): a tendency towards stabilization in cognitive status; the plasma levels of A beta peptides didn't show a clear pattern; and the brain-imaging assessment suggested a progressive volume increase in the hippocampus. The clinical trial reported in the experimental group vs control (2): a better score for the cognitive status; an increase of plasma A beta peptides; and did not find significant differences between groups for cerebrospinal fluid A beta peptides. The brain-imaging assessment showed a progressive loss of hippocampus volume in both groups. Regarding safety, the studies didn't report quantitative data. We didn't find economic evaluation studies. CONCLUSIONS: The included studies had very high risk of bias and very low quality. We found no evidence on efficacy and safety of plasmapheresis treating AD. Plasmapheresis isn't a priority line in research of AD treatment." @default.
- W2783845384 created "2018-01-26" @default.
- W2783845384 creator A5010830024 @default.
- W2783845384 creator A5033939043 @default.
- W2783845384 creator A5044223388 @default.
- W2783845384 creator A5067206068 @default.
- W2783845384 date "2017-01-01" @default.
- W2783845384 modified "2023-10-16" @default.
- W2783845384 title "VP168 Assessment Of Plasmapheresis For Alzheimer's Disease Systematic Review" @default.
- W2783845384 cites W1999168176 @default.
- W2783845384 cites W2077514576 @default.
- W2783845384 doi "https://doi.org/10.1017/s0266462317004044" @default.
- W2783845384 hasPublicationYear "2017" @default.
- W2783845384 type Work @default.
- W2783845384 sameAs 2783845384 @default.
- W2783845384 citedByCount "1" @default.
- W2783845384 countsByYear W27838453842020 @default.
- W2783845384 crossrefType "journal-article" @default.
- W2783845384 hasAuthorship W2783845384A5010830024 @default.
- W2783845384 hasAuthorship W2783845384A5033939043 @default.
- W2783845384 hasAuthorship W2783845384A5044223388 @default.
- W2783845384 hasAuthorship W2783845384A5067206068 @default.
- W2783845384 hasConcept C118552586 @default.
- W2783845384 hasConcept C126322002 @default.
- W2783845384 hasConcept C15744967 @default.
- W2783845384 hasConcept C159654299 @default.
- W2783845384 hasConcept C169900460 @default.
- W2783845384 hasConcept C1862650 @default.
- W2783845384 hasConcept C203014093 @default.
- W2783845384 hasConcept C2778373026 @default.
- W2783845384 hasConcept C2778842783 @default.
- W2783845384 hasConcept C2779134260 @default.
- W2783845384 hasConcept C2779483572 @default.
- W2783845384 hasConcept C502032728 @default.
- W2783845384 hasConcept C535046627 @default.
- W2783845384 hasConcept C58693492 @default.
- W2783845384 hasConcept C71924100 @default.
- W2783845384 hasConceptScore W2783845384C118552586 @default.
- W2783845384 hasConceptScore W2783845384C126322002 @default.
- W2783845384 hasConceptScore W2783845384C15744967 @default.
- W2783845384 hasConceptScore W2783845384C159654299 @default.
- W2783845384 hasConceptScore W2783845384C169900460 @default.
- W2783845384 hasConceptScore W2783845384C1862650 @default.
- W2783845384 hasConceptScore W2783845384C203014093 @default.
- W2783845384 hasConceptScore W2783845384C2778373026 @default.
- W2783845384 hasConceptScore W2783845384C2778842783 @default.
- W2783845384 hasConceptScore W2783845384C2779134260 @default.
- W2783845384 hasConceptScore W2783845384C2779483572 @default.
- W2783845384 hasConceptScore W2783845384C502032728 @default.
- W2783845384 hasConceptScore W2783845384C535046627 @default.
- W2783845384 hasConceptScore W2783845384C58693492 @default.
- W2783845384 hasConceptScore W2783845384C71924100 @default.
- W2783845384 hasIssue "S1" @default.
- W2783845384 hasLocation W27838453841 @default.
- W2783845384 hasOpenAccess W2783845384 @default.
- W2783845384 hasPrimaryLocation W27838453841 @default.
- W2783845384 hasRelatedWork W2023485724 @default.
- W2783845384 hasRelatedWork W2160269994 @default.
- W2783845384 hasRelatedWork W2165840723 @default.
- W2783845384 hasRelatedWork W2411470482 @default.
- W2783845384 hasRelatedWork W2803278045 @default.
- W2783845384 hasRelatedWork W2998575611 @default.
- W2783845384 hasRelatedWork W3184996520 @default.
- W2783845384 hasRelatedWork W4210986086 @default.
- W2783845384 hasRelatedWork W4283517038 @default.
- W2783845384 hasRelatedWork W4306404621 @default.
- W2783845384 hasVolume "33" @default.
- W2783845384 isParatext "false" @default.
- W2783845384 isRetracted "false" @default.
- W2783845384 magId "2783845384" @default.
- W2783845384 workType "article" @default.